MONTREAL, QUEBEC--(Marketwire - August 05, 2008) - Ambrilia Biopharma Inc. (TSX: AMB) today announced that Dr. Philippe Calais, President and CEO, will present the Company and its projects at the Canaccord Adams 28th Annual Global Growth Conference to be held in Boston, August 12-14. This presentation will take place on Thursday, August 14, at 8:00 am local time.
